abstract |
The present application relates to radiolabeled cyclic polypeptides, pharmaceutical compositions comprising radiolabeled cyclic polypeptides, and methods of using radiolabeled cyclic polypeptides. Such polypeptides can be used in imaging studies such as positron emission tomography (PET) or single photon emission computed tomography (SPECT). |